Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project-Reference-Cited by-同舟云学术

Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project

Published:2021-03-04 Issue:1 Volume:149 Page:66-74
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nagel Gabriele¹²^ORCID,Bjørge Tone³⁴^ORCID,Jaensch Andrea¹,Peter Raphael S.¹,Häggström Christel⁵⁶^ORCID,Lang Alois²,Engeland Anders³⁷^ORCID,Teleka Stanley⁸^ORCID,Jirström Karin⁸,Lindquist David⁹,Stattin Pär⁶,Ulmer Hanno¹⁰,Concin Hans²,Stocks Tanja⁸^ORCID

Affiliation:

1. Institute of Epidemiology and Medical Biometry, Ulm University Ulm Germany

2. Agency for Preventive and Social Medicine (aks) Bregenz Austria

3. Department of Global Public Health and Primary Care University of Bergen Bergen Norway

4. Cancer Registry of Norway Oslo Norway

5. Department of Public Health and Clinical Medicine Umeå University Umeå Sweden

6. Department of Surgical Sciences Uppsala University Uppsala Sweden

7. Division of Mental and Physical Health Norwegian Institute of Public Health Bergen Norway

8. Department of Clinical Sciences Lund Lund University Lund Sweden

9. Department of Clinical Sciences Umeå University Umeå Sweden

10. Department of Medical Statistics, Informatics and Health Economics Medical University of Innsbruck Innsbruck Austria

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33530

Reference29 articles.

1. The burden of rare cancers in the United States

2. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

3. Epidemiology of cancers of the small intestine: trends, risk factors, and prevention;Barsouk A;Med Sci (Basel),2019

4. Epidemiology of cancer of the small intestine

5. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study;The Lancet Regional Health - Europe;2024-10

2. Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms;BMC Cancer;2024-06-17

3. Gastric cancer and metabolic syndrome;Kosin Medical Journal;2024-03-31

4. Body Mass Index and Risk of Over 100 Cancer Forms and Subtypes in 4·1 Million Individuals in Sweden: The Obesity and Disease Development Sweden (ODDS) Pooled Cohort Study;2024

5. The Role of Pentraxin 3 in Gastrointestinal Cancers;Cancers;2023-12-14